20182017201620152014 | 2013 | 2012


Nelarabine May Improve Disease-Free Survival in Pediatric and Young Adult T-cell ALL

Nelarabine May Improve Disease-Free Survival in Pediatric and Young Adult T-cell ALL

The efficacy of nelarabine among newly diagnosed patients with T-cell ALL has not been fully explored.

Lung Cancer Screening Rates Inadequate in United States Despite USPSTF Recommendations

Lung Cancer Screening Rates Inadequate in United States Despite USPSTF Recommendations

Current literature reflects estimates, but not actual rates, of low-dose computed tomography adherence across the United States.

Cognitive Behavioral Therapy Compared With Acupuncture for Insomnia in Cancer Survivors

Cognitive Behavioral Therapy Compared With Acupuncture for Insomnia in Cancer Survivors

Investigators sought to determine whether cognitive behavioral therapy or acupuncture was more effective in addressing insomnia in this population.

CYCORE System May Improve Radiotherapy-Associated Symptoms in Head and Neck Cancer

CYCORE System May Improve Radiotherapy-Associated Symptoms in Head and Neck Cancer

The CYCORE system may enable physicians to intervene at the early signs of dehydration and other radiotherapy-associated symptoms.

Pembrolizumab Shows Activity Among Some Young Patients With Advanced Sarcoma

Pembrolizumab Shows Activity Among Some Young Patients With Advanced Sarcoma

PD-1 inhibition with pembrolizumab may be an effective treatment option for adolescent and young adult patients with some sarcoma subtypes.

Potential Clinical Benefit in Multigene Hereditary Testing for Patients With Sarcoma

Potential Clinical Benefit in Multigene Hereditary Testing for Patients With Sarcoma

There may be potential clinical benefits to performing hereditary cancer risk assessments and multi-gene panel testing in patients with sarcoma.

Talimogene Laherparepvec Plus Ipilimumab Promising for Advanced Melanoma

Talimogene Laherparepvec Plus Ipilimumab Promising for Advanced Melanoma

Talimogene laherparepvec plus ipilimumab improves the overall response rate over ipilimumab alone among patients with unresected, advanced melanoma.

In Focus: Abemaciclib for Advanced Breast Cancer

In Focus: Abemaciclib for Advanced Breast Cancer

Several presentations demonstrated that abemaciclib provides clinical benefit for women with HR+/HER2-negative breast cancer who progress on or are resistant to endocrine therapy.

Future Treatment Modalities in Sarcoma: Insights From ASCO 2017

Future Treatment Modalities in Sarcoma: Insights From ASCO 2017

Targeted and immunotherapeutic approaches are poised to change how sarcoma will be treated in the future. Trials are being used to match tumors with appropriate treatment choices.

Overcoming Drug Resistance in the Treatment of Metastatic Breast Cancer

Overcoming Drug Resistance in the Treatment of Metastatic Breast Cancer

The management of metastatic breast cancer resistant or refractory to hormonal treatments, while still challenging, is rapidly improving.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs